The present study demonstrated that administering OXY effectively improves cognitive impairments and episodic-like memory by transforming BV-2 from M1 proinflammatory phenotype to M2 anti-inflammatory phenotype, attenuating LPS-induced neuroinflammation and neuronal damage in the hippocampus and cortex. The gene discussed is GCG; the disease is Cognitive impairment.